Digirad Co. (NASDAQ:DRAD) Director Jeffrey E. Eberwein acquired 15,000 shares of the business’s stock in a transaction on Friday, March 15th. The shares were bought at an average price of $0.74 per share, with a total value of $11,100.00. Following the completion of the transaction, the director now directly owns 559,152 shares of the company’s stock, valued at $413,772.48. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
DRAD stock traded up $0.15 during mid-day trading on Friday, hitting $0.85. 763,905 shares of the company were exchanged, compared to its average volume of 81,857. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.60. Digirad Co. has a 1-year low of $0.42 and a 1-year high of $2.00.
An institutional investor recently bought a new position in Digirad stock. Price Wealth Management Inc. acquired a new position in shares of Digirad Co. (NASDAQ:DRAD) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 61,000 shares of the medical equipment provider’s stock, valued at approximately $35,000. Price Wealth Management Inc. owned about 0.30% of Digirad as of its most recent SEC filing. 38.83% of the stock is currently owned by institutional investors and hedge funds.
Digirad Company Profile
Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services.
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.